- Supplementary Figre 1[supplements/310105_file07.jpg]
- Supplementary Figre 2[supplements/310105_file08.jpg]
- Supplementary Figre 3[supplements/310105_file09.jpg]
- Supplementary Figre 4[supplements/310105_file10.jpg]
- Supplementary Table 1[supplements/310105_file11.xlsx]
- Supplementary Table 2[supplements/310105_file12.xlsx]
- Supplementary Table 3[supplements/310105_file13.xlsx]
- Supplementary Table 4[supplements/310105_file14.xlsx]
- Supplementary Table 5[supplements/310105_file15.xlsx]
![[supplements/310105_file07.jpg]](https://www.medrxiv.org/content/medrxiv/early/2024/07/12/2024.07.11.24310105/DC1/embed/media-1.jpg?download=true){kind=link}
![[supplements/310105_file08.jpg]](https://www.medrxiv.org/content/medrxiv/early/2024/07/12/2024.07.11.24310105/DC2/embed/media-2.jpg?download=true){kind=link}
![[supplements/310105_file09.jpg]](https://www.medrxiv.org/content/medrxiv/early/2024/07/12/2024.07.11.24310105/DC3/embed/media-3.jpg?download=true){kind=link}
![[supplements/310105_file10.jpg]](https://www.medrxiv.org/content/medrxiv/early/2024/07/12/2024.07.11.24310105/DC4/embed/media-4.jpg?download=true){kind=link}
Posted July 12, 2024.
Low-dose chemotherapy combined with delayed immunotherapy in the neoadjuvant treatment of non-small cell lung cancer and dynamic monitoring of the drug response in peripheral blood
